BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Yu A. The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells. J Cancer Res Clin Oncol 2015;141:2071-7. [DOI: 10.1007/s00432-015-1916-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Godel M, Ortone G, Anobile DP, Pasino M, Randazzo G, Riganti C, Kopecka J. Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer. Pharmaceutics 2021;13:762. [PMID: 34065551 DOI: 10.3390/pharmaceutics13050762] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Avolio R, Matassa DS, Criscuolo D, Landriscina M, Esposito F. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer. Biomolecules 2020;10:E135. [PMID: 31947673 DOI: 10.3390/biom10010135] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
3 Ismail T, Kim Y, Lee H, Lee DS, Lee HS. Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression. Int J Mol Sci 2019;20:E4407. [PMID: 31500275 DOI: 10.3390/ijms20184407] [Cited by in Crossref: 22] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
4 Kim Y, Jang HH. The Role of Peroxiredoxin Family in Cancer Signaling. J Cancer Prev 2019;24:65-71. [PMID: 31360686 DOI: 10.15430/JCP.2019.24.2.65] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
5 Cui Q, Wang J, Assaraf YG, Ren L, Gupta P, Wei L, Ashby CR, Yang D, Chen Z. Modulating ROS to overcome multidrug resistance in cancer. Drug Resistance Updates 2018;41:1-25. [DOI: 10.1016/j.drup.2018.11.001] [Cited by in Crossref: 155] [Cited by in F6Publishing: 230] [Article Influence: 38.8] [Reference Citation Analysis]
6 Huynh DL, Zhang JJ, Chandimali N, Ghosh M, Gera M, Kim N, Park YH, Kwon T, Jeong DK. SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis. Biochem Biophys Res Commun 2018;503:2248-54. [PMID: 29958885 DOI: 10.1016/j.bbrc.2018.06.145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
7 Koudelkova P, Costina V, Weber G, Dooley S, Findeisen P, Winter P, Agarwal R, Schlangen K, Mikulits W. Transforming Growth Factor-β Drives the Transendothelial Migration of Hepatocellular Carcinoma Cells. Int J Mol Sci 2017;18:E2119. [PMID: 28994702 DOI: 10.3390/ijms18102119] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
8 Benfeitas R, Uhlen M, Nielsen J, Mardinoglu A. New Challenges to Study Heterogeneity in Cancer Redox Metabolism. Front Cell Dev Biol 2017;5:65. [PMID: 28744456 DOI: 10.3389/fcell.2017.00065] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
9 Nicolussi A, D'Inzeo S, Capalbo C, Giannini G, Coppa A. The role of peroxiredoxins in cancer. Mol Clin Oncol 2017;6:139-53. [PMID: 28357082 DOI: 10.3892/mco.2017.1129] [Cited by in Crossref: 78] [Cited by in F6Publishing: 100] [Article Influence: 15.6] [Reference Citation Analysis]
10 Lee S, Wi SM, Min Y, Lee KY. Peroxiredoxin-3 Is Involved in Bactericidal Activity through the Regulation of Mitochondrial Reactive Oxygen Species. Immune Netw 2016;16:373-80. [PMID: 28035213 DOI: 10.4110/in.2016.16.6.373] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
11 Odnokoz O, Nakatsuka K, Klichko VI, Nguyen J, Solis LC, Ostling K, Badinloo M, Orr WC, Radyuk SN. Mitochondrial peroxiredoxins are essential in regulating the relationship between Drosophila immunity and aging. Biochim Biophys Acta Mol Basis Dis 2017;1863:68-80. [PMID: 27770625 DOI: 10.1016/j.bbadis.2016.10.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
12 Yewdall NA, Venugopal H, Desfosses A, Abrishami V, Yosaatmadja Y, Hampton MB, Gerrard JA, Goldstone DC, Mitra AK, Radjainia M. Structures of Human Peroxiredoxin 3 Suggest Self-Chaperoning Assembly that Maintains Catalytic State. Structure 2016;24:1120-9. [PMID: 27238969 DOI: 10.1016/j.str.2016.04.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
13 Zeida A, Reyes AM, Lichtig P, Hugo M, Vazquez DS, Santos J, González Flecha FL, Radi R, Estrin DA, Trujillo M. Molecular Basis of Hydroperoxide Specificity in Peroxiredoxins: The Case of AhpE from Mycobacterium tuberculosis. Biochemistry 2015;54:7237-47. [DOI: 10.1021/acs.biochem.5b00758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]